Albert David Faces Significant Volatility Amid Broader Market Challenges and Deteriorating Trends
Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The stock has underperformed recently, trading below key moving averages and facing a substantial decline in operating profit over the past five years, alongside a negative quarterly performance.
Albert David, a microcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, hitting a new 52-week low of Rs. 773.3. This decline marks a notable underperformance, with the stock down 10.63% over the past two days and 2.96% below its sector average today. The stock opened with a gap down of 4.9%, reaching an intraday low of Rs. 773.3, reflecting ongoing bearish sentiment.In terms of technical indicators, Albert David is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signaling a deteriorating trend. The broader market, represented by the Sensex, has also faced challenges, recovering slightly after a significant drop but remaining 3.49% away from its own 52-week low.
Financially, Albert David has struggled with a -34.86% return over the past year, significantly underperforming the BSE 500 index, which saw a decline of -3.84%. The company's operating profit has decreased at an annual rate of -21.75% over the last five years, compounded by a recent negative quarterly performance, including a PAT of Rs -9.39 crore. Despite a low debt-to-equity ratio and an attractive valuation, the stock's technical outlook remains bearish.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
